KBC Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-9,155
| Closed | -$930K | – | 1863 |
|
|
2025
Q4 | $930K | Sell |
9,155
-4,367
| -32% | -$351K | ﹤0.01% | 681 |
|
|
2025
Q3 | $740K | Sell |
13,522
-295
| -2% | -$14.7K | ﹤0.01% | 686 |
|
|
2025
Q2 | $734K | Sell |
13,817
-13,925
| -50% | -$707K | ﹤0.01% | 677 |
|
|
2025
Q1 | $1.2M | Hold |
27,742
| – | – | ﹤0.01% | 652 |
|
|
2024
Q4 | $1.56M | Buy |
27,742
+490
| +2% | +$30.5K | ﹤0.01% | 726 |
|
|
2024
Q3 | $1.86M | Buy |
27,252
+5,368
| +25% | +$303K | 0.01% | 627 |
|
|
2024
Q2 | $924K | Hold |
21,884
| – | – | ﹤0.01% | 673 |
|
|
2024
Q1 | $1.51M | Hold |
21,884
| – | – | ﹤0.01% | 620 |
|
|
2023
Q4 | $1.62M | Sell |
21,884
-21,199
| -49% | -$1.39M | 0.01% | 635 |
|
|
2023
Q3 | $2.94M | Buy |
43,083
+5,950
| +16% | +$505K | 0.01% | 529 |
|
|
2023
Q2 | $3.49M | Sell |
37,133
-63,979
| -63% | -$4.99M | 0.01% | 512 |
|
|
2023
Q1 | $6.86M | Buy |
101,112
+49,494
| +96% | +$3.18M | 0.03% | 426 |
|
|
2022
Q4 | $2.56M | Sell |
51,618
-165,160
| -76% | -$6.75M | 0.01% | 563 |
|
|
2022
Q3 | $7.04M | Sell |
216,778
-25,668
| -11% | -$1.06M | 0.04% | 341 |
|
|
2022
Q2 | $9.55M | Sell |
242,446
-332,884
| -58% | -$17.8M | 0.05% | 304 |
|
|
2022
Q1 | $40.2M | Buy |
575,330
+83,122
| +17% | +$6.08M | 0.16% | 157 |
|
|
2021
Q4 | $38.3M | Buy |
492,208
+315,078
| +178% | +$27.8M | 0.13% | 182 |
|
|
2021
Q3 | $16.9M | Buy |
177,130
+119,070
| +205% | +$12.6M | 0.06% | 282 |
|
|
2021
Q2 | $7.22M | Sell |
58,060
-5,754
| -9% | -$687K | 0.01% | 544 |
|
|
2021
Q1 | $8.41M | Buy |
63,814
+25,488
| +67% | +$3.49M | 0.02% | 496 |
|
|
2020
Q4 | $27.9M | Buy |
38,326
+12,324
| +47% | +$1.49M | 0.01% | 589 |
|
|
2020
Q3 | $2.65M | Sell |
26,002
-12,420
| -32% | -$1.07M | 0.01% | 661 |
|
|
2020
Q2 | $3.34M | Buy |
38,422
+18,392
| +92% | +$1.47M | 0.01% | 599 |
|
|
2020
Q1 | $1.16M | Buy |
20,030
+7,116
| +55% | +$578K | 0.01% | 666 |
|
|
2019
Q4 | $1.19M | Buy |
+12,914
| New | +$1.14M | 0.01% | 842 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
KBC Group's EXAS Position: Q1 2026 in Review
KBC Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 9,155 shares — an estimated $930K sold.
KBC Group first reported a position in EXAS in Q4 2019 and held it in 25 quarters. The position peaked at $40.2M in Q1 2022. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- KBC Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- KBC Group sold 9,155 Exact Sciences shares in Q1 2026, an estimated $930K.
- KBC Group first reported a position in Exact Sciences in Q4 2019 and held it in 25 quarters.
- KBC Group's Exact Sciences position peaked at $40.2M in Q1 2022.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.